Faron Pharmaceuticals Oy Share Discussion Threads

[mustau] 02/5/2019 15:42

Wtf, just looked in. Small holding from the 60p region.
I know they are in talks with a few Pharmas but thought anything tangible would likely be next year.

[inv] 02/5/2019 13:48

this has started to surge and will continue

[newtothisgame3] 11/4/2019 12:18

INTERVIEW #FARN Faron Pharma to expand its Clevegen trial to focus on Colorectal cancer

[daffodil4] 03/4/2019 15:09

What are the thoughts on last weeks RNS??

Are they looking at Equity Draw down as the City do not
want to invest further? YODA delay buried in the RNS!

Good the placing was not heavily discounted....but only
3 months money left!!! I wish they had given a more accurate
timescale for YODA results....does anyone think we will
get a Partner deal before the funds run out???

AVIVA sold a small amount but if that continues I
may see that as a signal we are going for finance
and that would be a sell....interested in any other
views.....Clevegen is the gem here, but it has a
long way to go!

[bad gateway] 26/3/2019 16:05

Yeah may have been too neg this morning, decent placing price today at least. Just didn't take well to reading they're placing today, its not enough so they may go for equity drawdown financing later in the year.
Been there done that and it didn't end well.

[ic0gcds00] 26/3/2019 13:03

Theres nothing like a neg lol

[bad gateway] 26/3/2019 07:26

Shame got just a few of these tucked away in case they came good but bottom of todays placing news they state that this round of funding won't be enough for 12 months (which is fair enough) and that they are looking at other sources of finance including death spiral finance.
Think this shows they have no clue and pi's won't make anything here.

"in addition to the Fundraise, the Company is exploring a variety of additional sources of funding and longer term funding arrangements, including discussions with potential licensees, grants, strategic investors, soft loans and an equity draw down facility. Discussions are ongoing across funding arrangements and further announcements will be made as and when required."

They may not go for the equity drawdown facility (and pigs may fly) but the fact they'd even consider it makes them uninvestable from hereon in imo.

[czeck] 14/3/2019 12:19

Faron Pharmaceuticals, Ltd. is at present engaged in the development of pharmacological treatments for acute lung injury with the help of a consortium consisting European Commission, Traumakine program (University College London Hospital (UCLH) and University of Torino and University of Turku). The FP-1201-lyo treatment for acute lung injury is now in the 3rd phase of clinical trials and is anticipated to obtain European marketing authorization in the near future.

[dave4545] 28/2/2019 09:49

That chart is showing potential. Short term trading opp as it does spike and get chased a lot from these levels at times.

[newtothisgame3] 26/2/2019 13:02

Here's why Faron Pharma is worth watching for a future trigger
by Alistair Strang from Trends and Targets | 25th February 2019 08:33
Faron took a dive last year, but can it turn things around? Our chartist looks at the key numbers.

[newtothisgame3] 26/2/2019 13:00

Faron Pharmaceuticals makes good start to Clevegen immunotherapy trial
14:30 25 Feb 2019

[superadams] 24/2/2019 23:01

Sorry, thought from something I read that Clevegen and Trauamkine were connected. Fact remains that CMS have a big 5 age of FARN and I think they might bid if it has a sparkling future.

[dan1nat1] 24/2/2019 22:42

What Traumakine news?

[superadams] 22/2/2019 12:06

Thanks guys. My largest holding ( 12 bagger ) is China Medical System Holdings which was up 9% last night on Trauamkine news. You might consider switching into CMS for continuing exposure to Faron and this treatment but a 4.7% yield in the meantime. Not ramping. DYOR. GLA.

[inv] 21/2/2019 15:03

excellent news

[jayj4u] 21/2/2019 09:08

Everyone who holds..... Just relax... the last few RNS are too good to be ignored. This will move towards £1 in the coming days.

I will asking BOD to do an interview.

[davidlloyd] 21/2/2019 08:37

Agree- likely to be some nervous short positions here I feel.
DL

[pre] 21/2/2019 08:24

well excellent news...engaged in discussions with several partners...should be much much higher imo, dyor etc

[safman] 21/2/2019 08:06

Dr Markku Jalkanen, Chief Executive Officer of Faron, said: "We have previously shown that Clevegen has the ability in experimental settings to convert the macrophage population from immune suppressive macrophages to immune active myeloid cells, which are believed to initiate the tumour fight by host immune cells. These initial data from the MATINS trial appear to confirm that this immune switch can also take place in cancer patients. We are very encouraged by these findings, and by the potential early clinical benefits indicated through the biochemical and tumour load indicators, following several lines of previous ineffective treatments. These biomarker data will prove valuable to help determine the optimal dose as the trial continues and we look forward to generating further data to assess durability of effect and efficacy in a larger number of patients."

saffy...

[thecashmoney] 21/2/2019 08:01

Excellent news here this morning. How many of these can I grab . 👌